Applications of 99mTc-SestaMIBI in oncology

Tumori

Volumn 82, Issue 1, 1996, Pages 12-21

  Maffioli, Lorenzo ^a   Steens, Jeroen ^b   Pauwels, Ernest ^b   Bombardieri, Emilio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

99mTc SestaMIBI; Alkylisonitrile complexes; P glycoprotein; Tumor seeking agents

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; DIAGNOSTIC AGENT;

CANCER; DRUG TARGETING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; BONE TUMOR; BRAIN TUMOR; BREAST TUMOR; LUNG TUMOR; NASOPHARYNX TUMOR; NEOPLASM; SCINTISCANNING; THYROID TUMOR;

BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; HUMANS; LUNG NEOPLASMS; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS; P-GLYCOPROTEIN; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS;

EID: 0029665069     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200103     Document Type: Article

References (59)

1. Aktolun C., Demirel D., Kir M.: Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis. J. Nucl. Med., 32: 1429-1431, 1991.
2. Backus M., Piwnica-Worms D., Hockett D.: Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential. Am. Phys. Soc., 178-187, 1993.
3. Baillet G., Albuquerque L., Chen Q., Poisson M., Delattre J.Y.: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur. J. Nucl. Med., 21: 1061-1066, 1994.
4. Balon R.H., Fink-Bennett D., Stoffer S.S.: Technetium-99m-SestaMIBI uptake by recurrent Hürthle cell carcinoma of the thyroid. J. Nucl. Med., 33: 1393-1395, 1992.
5. 99mTc-MIBI: a comparative study with mammography and ultrasonography. Nucl. Med. Comm., 15: 604-612, 1994.
6. Caner B., Kitapçi M., Aras T., Erbengi G., Ugur O., Bekdik C.: Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in osteosarcoma and its metastatic lymph nodes. J. Nucl. Med., 32: 1977-1978, 1991.
7. Caner B., Kitapçi M., Unlü M.., Erbengi G., Çalikoglu T., Gögüs T., Bekdik C.: Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in osteosarcoma and its metastatic lymph nodes. J. Nucl. Med., 33: 319-324, 1992.
8. Carrol M.J., Solanki K.K., Britton K.E., Besser G.M.: Change detection and movement correction for parathyroid imaging with Tc-99m MIBI. J. Nucl. Med., 32: 1011, 1991.
9. Carvalho A.P., Chiu L.M., Kronauge J.F.: Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J. Nucl. Med., 33: 1516-1522, 1992.
10. Chernoff D.M., Strichartz G.R., Piwnica-Worms D.: Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutylisonitrile)technetium(I). Bioch. Biophys. Acta, 1147: 262-266, 1993.
11. Chiti A., Maffioli L.S., Infante M., Grasselli G., Incarbone M., Gasparini M.D., Savelli G., Bombardieri E.: Assessment of mediastinal involvement in lung cancer with 99mTc-SestaMIBI SPET. J. Nucl. Med. (in press).
12. Chiu L.M., Kronauge J.F., Piwnica-Worms D.: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J. Nucl. Med., 31: 1646-1653, 1990.
13. Coakley A.J., Kettle A.G., Wells C.P.: 99m-Tc-SestaMIBI - A new agent for parathyroid imaging. Nucl. Med. Commun., 10: 791-794, 1989.
14. Grippa F., Agresti R., Bombardieri E., Seregni E., Chiti A., Greco M., Andreola S., Buraggi G.L., Veronesi U.: Prelimi-nary results of pre-operative axillary radioimmunoscintigraphy with In-111 B72.3 in breast cancer. Int. J. Oncol., 6: 791-795, 1995.
15. Delmon-Moingeon L.I., Piwnica-Worms D., Vanden Abbeele A.: Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res., 50: 2198-2202, 1990.
16. Dimitrakopoulou-Strauss A., Strauss LG., Goldschmidt H., Lorenz WJ., van Kaick G.: FDG-PET and Tc-99m-SestaMIBI SPECT for therapy management in patients with treated malignant lymphomas. Eur. J. Nucl. Med., 10: S7, 1994.
17. Dimitriakopoulou-Srauss A., Strauss L.G., Goldschmidt H., Lorenz W.J., Van Kaick G.: FDG-PET and Tc-99m-SestaMIBI-SPECT for therapy management in patients with treated malignant lymphomas. Eur. J. Nucl. Med., 10: S7, 1994.
18. Ferlin G., Borsato N., Camerani M., Conte N., Zotti D.: New perspectives in localizing enlarged parathyroids by thalliumtechnetium subtraction scan. J. Nucl. Med., 24: 438-441, 1983.
19. Geatti O., Shapiro B., Orsolon P.G., Proto G., Guerra U.P., Antonucci F., Gasparini D.: Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. Eur. J. Nucl. Med., 21: 17-22, 1994.
20. Kao C.H., Wang S.J., Lin W.Y., Hsu C.Y., Liao S.Q., Yeh S.H.: Detection of nasopharyngeal carcinoma using 99mTc-methoxyisobutylisonitrile SPECT. Nucl. Med. Comm., 14: 41-46, 1993.
21. Kao C.H., Wang S.J., Lin W.Y., Hsu C.Y., Liao S.Q., Yeh S.H.: Differentiation of single solid lesions in the lungs by means of SPET. Eur. J. Nucl. Med., 20(3): 249-54, 1993.
22. Khalkhali I., Cutrone J., Mena I., Diggles L., Venegas R., Vargas H.: Clinical and pathological follow-up of 100 patients with breast lesions studied with scintimammography (SMM). J. Nucl. Med., 35: 22P, 1994.
23. Kitapçi M.T., Tastekin G., Turgut M.: Preoperative localization of parathyroid carcinoma using Tc-99m MIBI. Clin. Nucl. Med., 18: 217-219, 1993.
24. Lebouthillier G., Morais J., Picard M., Picard D., Chartrand R., D'Amour P.: Tc-99m SestaMIBI and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin. Nucl Med, 18: 657-661, 1993.
25. LeBouthillier G., Taillefer R., Lambert R.: Detection of primary lung cancer with 99mTc-SestaMIBI. J. Nucl. Med., 34: 140p, 1993.
26. Maffioli L., Gasparini M., Chiti A., Gramaglia A., Mongioj V., Pozzi A., Bombardieri E.: Clinical role of Tc-99m-SestaMIBI SPET in evaluating pretreated patients with brain tumours. Eur. J. Nucl. Med. (in press).
27. Menendez L.R., Fideler B.M., Mirra J.: Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma J. Bone Joint Surgery, 75: 526-531, 1993.
28. Miles K.A., Barber R.W., Wraight E.P.: Leg muscle scintigraphy with 99m-Tc-MIBI in the assessment of peripheral vascular (arterial) disease. Nucl. Med. Comm., 13: 593-603, 1992.
29. Moretti J-L., Caglar M., Boaziz C., Caillat-Vigneron N., Morere J-F.: Sequential functional imaging with technetium-99m hexakis-2-methoxyisobutylisonitrile and indium- 111 octreotide: can we predict the response to chemotherapy in small cell lung cancer? Eur. J. Nucl. Med., 22: 177-180, 1995.
30. Moretti J-L., Caglar M., Duran-Cordobes M., Morere J-F.: Can nuclear medicine predict response to chemotherapy? Eur. J. Nucl. Med., 22: 97-100, 1995.
31. Nagarai N., Waxman A., Ashok G., Khan S., Memsic L., Yadegar J., Phillips E.: Comparison of SPECT and planar Tc-99m SestaMIBI (MIBI) imaging in patients with carcinoma of the breast. J. Nucl. Med., 35: 222P, 1994.
32. Nathan M.A., Seabold J.E., Barloon T., Quesenberry J., Bushnell D.L., Robinson R.A., Young D.C., Kirchner P.T.: Planar vs SPECT Tc-99m MIBI evaluation of suspicious breast lesions on mammography: histologic correlation. J. Nucl. Med., 35: 222P, 1994.
33. O'Doherty M.J., Kettle GA.., Wells P.: Parathyroid imaging with technetium-99m-sestaMIBI: preoperative localization and tissue uptake studies. J. Nucl. Med., 33: 313-318, 1992.
34. O'Driscoll C.M., Baker F., Casey M.J., Duffy G.J.: Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylisomtrile scintigraphy: a case report. J. Nucl. Med., 32: 2281-2283, 1991.
35. O'Tuama A., Packard A.B., Treves S.T.: Spect imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J. Nucl. Med., 31: 2040-2041, 1990.
36. O'Tuama L.A., Treves S.T., Larar J.N.: Thallium-201 versus technetium-99m-MIBI SPET in evaluation of childhood brain tumors: a within-subject comparison. J. Nucl. Med., 34: 1045-1051, 1993.
37. Oriuchi N., Tamura M., Shibazaki T: Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J. Nucl. Med., 34: 2085-2089, 1993.
38. 201Tl by a 9L gliosarcoma brain tumor model in rats. Nucl. Med. Biol., 20: 773-776, 1993.
39. Park C.H., Kim S.M., Zhang J.J.: Tc-99m MIBI brain SPET in the diagnosis of recurrent glioma. Clin. Nucl. Med., 19: 57-58, 1994.
40. Piwnica-Worms D., Chiu M.I., Croop J.M.: Enhancement of Tc-99m-SestaMIBI accumulation in multidrug resistant (MDR) cells by cytotoxic drugs and MDR reversing agents. J. Nucl. Med., 34: 140p, 1993.
41. Piwnica-Worms D., Chiu M.L., Budding M.: Functional imaging of multidrug-resistant P-glycoprotein with an organote-chnetium complex. Cancer Res., 53: 977-984, 1993.
42. Piwnica-Worms D., Chiu M.L., Kronauge J.F.: Divergent kinetics of 201Tl and 99mTc-SestaMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation, 85: 1531-1541, 1992.
43. Piwnica-Worms D., Holman B.L.: Editorial: noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J. Nucl. Med., 31: 1166-1167, 1990.
44. Piwnica-Worms D., Kronauge J.F., Chiu LM.: Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells. J. Nucl. Med., 32: 1992-1999, 1991.
45. Piwnica-Worms D., Kronauge J.F., Delmon L., Holman B.L., Marsh J.D., Jones A.G.: Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J. Nucl. Med., 31: 464-472, 1990.
46. Saletnich V., Rufini V., Salvatori M., Daidone M.S., Troncone L.: Assessment of Tl-201 and Tc-99m-MIBI efficacy in the follow up of selected patients harbouring differentiating thyroid carcinoma (DTC). Eur. J. Nucl. Med., 2: 864, 1994.
47. Sayman H.B., Urgancioglu I.: Muscle perfusion with technetium-MIBI in lower extremity peripheral arterial diseases. J. Nucl. Med., 32: 1700-1703, 1991.
48. Scopinaro F., De Vincentis G., Pani R., Pellegrini R., Banci M., Casu C., Lerardi M., Russo A., Soluri A.: 99mTc-MIBI uptake in green plants. Nuel. Med. Commun., 15: 905-915, 1994.
49. Scopinaro F., Schillaci O., Scarpini M., Mingazzini PL., Di Macio L., Banci M., Danieli R., Zerilli M., Limiti M.R., Centi Colella A.: Technetium-99m SestaMIBI an indicator of breast cancer invasiveness Eur. J. Nucl. Med., 21: 984-987, 1994.
50. Scott M.A., Kostakoglu L., O'Brien J.P.: Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J. Nucl. Med., 33: 1396-1398, 1992.
51. Stowasser G., Pernegger C., Brinninger G., Pesl K., Weiss M., Keiler A.: Evaluation of Tc-99m SestaMIBI (MIBI) in patients with suspected breast cancer in comparison with Tl-201. J. Nucl. Med., 35: 231P, 1994.
52. Sundram F.X., Goh A.S., Ang E.S.: Role of technetium-99m SestaMIBI in localisation of thyroid cancer metastases. Ann. Acad. Med. Singapore, 22(4): 557-559, 1993.
53. Sutter C.W., Joshi M.J., Stadalnik R.C.: Noncardiac uptake of technetium-99m MIBI. Sem. Nucl. Med., 24: 84-86, 1994.
54. Taillefer R., Boucher Y., Potvin C., Lambert R.: Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-SestaMIBI (Double phase study). J. Nucl. Med., 33: 1801-1807, 1992.
55. Valk P.E., Dillon W.P.: Diagnostic imaging of central nervous system radiation injury. In: Radiation injury to the central nervous system. Gutin PH, Leibel SA, Sheline GE (Eds.), pp. 211-237, Raven Press, New York, 1991.
56. Wann L.S., Hellnan C., Dorros G.: Evaluation of leg perfusion during exercise using technetium 99m sestaMIBI. Echocardiography, 9: 547-552, 1992.
57. Waxman A., Nagaraj N., Ashok G., Khan S., Yadegar J., Memsic L., Silberman A., Jochelson M., Katz R., Phillips E.: Sensitivity and specificity of Tc-99m methoxy isobutil isonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and non palpable lesions with mammography. J. Nucl. Med., 35: 22P, 1994.
58. Yen T-C., Lin H-D., Lee C-H., Chang S-L., Yeh S-H.: The role of technetium-99m SestaMIBI whole-body scans in diagnosing metastatic Hurtle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans. Eur. J. Nucl. Med., 21: 980-983, 1994.
59. Ziegels P., Nocaudie M., Huglo D., Deveaux M., Detourmignies L., Wattel E., Marchandise X.: Comparison of technetium-99 methoxyisobutylisontrile and gallium-67 citrate in the assessment of lymphomas. Eur. J. Nucl. Med., 22: 126-131, 1995.